CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending Type 2 diabetes diagnosis at 30 may cut life expectancy by 14 years: Lancet study Young Babita Phogat of Dangal fame passes away at 19 World Malaria Day: Pregnant women on high risk of malaria Latest ICMR starts first in-human clinical trials for Zika vaccine Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease NITI Ayog suggests separate legislation, fund for future pandemic Health ministry seeks action-taken report from hospitals on Kolkata incident
